Ocular Therapeutix -2.5% as holders file to sell 9.57M shares
Apr. 01, 2019 5:18 PM ETOcular Therapeutix, Inc. (OCUL)OCULBy: Jason Aycock, SA News Editor5 Comments
- Ocular Therapeutix (NASDAQ:OCUL) is 2.5% lower postmarket after shareholders filed to offer 9.57M shares.
- That filing proposes a maximum offering price of $3.94 each; shares closed today at $4.07.
- Of the 9.57M shares covered in the filing, 5.77M are issuable on the conversion of a senior subordinated convertible note between the company and an affiliate of Summer Road LLC, and 3.8M shares held by Summer Road affiliates.
- The selling stockholders are Cap 1 LLC (which has an 18.4% stake, and would exit its position) and East River Partners (with a 1.5% stake, and also would exit its position).